Terrestrosin D

Overview

Terrestrosin D is an orally active apoptosis inducer. Terrestrosin D induces cell cycle arrest at the G1 and S phases, reduces mitochondrial membrane potential, and inhibits the growth of cancer cells and endothelial cells. Terrestrosin D is studied in castration-resistant prostate cancer and pulmonary fibrosis.

Application

Products | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Castration-Resistant Prostate Cancer | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Cancer | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Prostate Cancer | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > VEGFR

Product Information

• Catalog No.: HY-N5074
• CAS No.: 179464-23-4
• Molecular Formula: C50H80O23
• Molecular Weight: 1049.16
• Purity: 99.30%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.5 mg/mL (2.38 mM); Clear solution
• Availability: In-stock

Source

Original product source